Although years since HIV diagnosis was similar among the two groups, excluded participants had higher Nadir and baseline CD4+ T-cell counts compared to participants who were included in the analysis and a lower proportion had prior AIDS defining illnesses. Antiretroviral therapy use at baseline and cumulative years of antiretroviral therapy use among users was also lower among those excluded.
A lower proportion of excluded participants were overweight or obese, had diabetes, hypertension, or hyperlipidemia, and statin and aspirin use were lower compared to participants who were included in the analysis. However it is important to keep in mind that those proportions are based only upon excluded participants for whom those measurements are available in HOPS medical records. Many excluded participants are missing various pieces of clinical data. Excluded participants had significantly fewer years of follow up (3.7 vs 6.5 years for excluded vs included participants respectively), significantly lower incidence of CVD events, and significantly higher incidence of non-CVD events (eTable 8). 
